CEO Today USA Awards

COUNTRY 63 material of the placenta into functional regeneration products to address serious wounds, burn and reconstructive surgical problems. We are always at the head of the power curve, and that is a critical factor in our success. What are your goals for the future? How are you aiming to achieve these? Our goals and aspirations are clear: we intend to be the leading company in cellular medicine and functional regeneration globally, and we aim to advance our products into the treatment of serious diseases including cancer, immunologic disease and degenerative disease. We are building a business that has the potential to eclipse the value of other cellular medicine approaches across the world in the next 3 to 5 years. At Celularity our focus is on progress, not process, as we advance the revolutions in cellular medicine and functional regeneration. I am not tolerant of complacency or maintenance of the status quo. I see the ability to deploy our cell therapeutic platforms to not just treat disease but to pre-empt it, all while maximizing human performance as we age. I see each breakthrough as a call to action to move the bar higher. I’m very fortunate in being able to attract and retain the best and brightest in the industry and see it as a central part of my job to lead by example. Q ABOUT DR. HARIRI Drawing from a diverse surgical, scientific, military and aerospace background, Dr. Robert ‘Bob’ Hariri is what Health and Technology Evangelist, John Nosta, has described as a “real- life Tony Stark”, bringing Ironman-like energy, determination and passion to regenerative medicine and human performance. “How many brain surgeon, rocket scientist, jet pilot, master scuba diver, corporate CEOs do you know?”, teases Nosta. Dr. Hariri is on a mission to transform the way diseases are treated, and health and performance are maintained by harnessing the unique regenerative power of the placenta. World authority on leadership psychology and world-renowned philanthropist, life and business coach and strategist, Tony Robbins, adds, “Bob has devoted his life to helping others and his track record in every facet of his career is nothing short of tireless and heroic. From his days as a trauma surgeon, mission pilot and corporate CEO, there are countless families that Bob has touched through his contributions to medicine, science and technology and I am so happy to call him my partner and dear friend.” A highly accomplished engineer, high-performance aviator, trauma neurosurgeon and biomedical scientist, Dr. Hariri has been a pioneer in the field of biotechnology and cell therapeutics for more than 25 years. After completing his undergraduate work in engineering and biology at Columbia University and receiving his M.D. and Ph.D. degrees from Cornell University, Dr. Hariri trained in surgery and neurosurgery at The New York Hospital-Cornell Medical Center. He started his first company while in medical school and has since built a number of companies from the ground up, including the genomic-based health intelligence leader, Human Longevity, Inc. But he also built the world’s first rocket-powered civilian airplane as part of the Rocket Racing League, and as a former college athlete, developed one of the world’s most effective muscle building supplements, Fortetropin at Myos, a company he founded focused on muscle health and performance. His pioneering cell therapy and regenerative medicine company, Anthrogenesis Corporation was acquired in 2002, becoming the cell-therapy division of biotechnology giant, Celgene Corporation. After leading that division for 15 years building an unprecedented cellular medicine platform technology, he spun his company out from Celgene and founded Celularity. Considered by many as one of the most dynamic and exciting chief executives in the industry, Dr. Hariri brings an unparalleled skillset, and unconventional approach to corporate culture and innovation to accelerate and differentiate Celularity in the world of biotechnology. “Genius is seeing the obvious 20 years ahead of the rest of us. Two decades ago, Dr. Robert Hariri saw the possibilities that placenta stem cells could be become foundational to the future of medicine. Today, Celularity has transformed this most natural and pure source material into cellular therapies that can cure cancer and will eventually be mass produced making cell therapies very affordable.” John Sculley former CEO of Apple